X-154477925-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_006014.5(LAGE3):c.*19G>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.137 in 1,184,933 control chromosomes in the GnomAD database, including 10,661 homozygotes. There are 56,667 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.21 ( 2495 hom., 6896 hem., cov: 24)
Exomes 𝑓: 0.13 ( 8166 hom. 49771 hem. )
Consequence
LAGE3
NM_006014.5 3_prime_UTR
NM_006014.5 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.989
Genes affected
LAGE3 (HGNC:26058): (L antigen family member 3) This gene belongs to the ESO/LAGE gene family, members of which are clustered together on chromosome Xq28, and have similar exon-intron structures. Unlike the other family members which are normally expressed only in testis and activated in a wide range of human tumors, this gene is ubiquitously expressed in somatic tissues. The latter, combined with the finding that it is highly conserved in mouse and rat, suggests that the encoded protein is functionally important. An intronless pseudogene with high sequence similarity to this gene is located on chromosome 9. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant X-154477925-C-G is Benign according to our data. Variant chrX-154477925-C-G is described in ClinVar as [Benign]. Clinvar id is 1235001.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.425 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LAGE3 | NM_006014.5 | c.*19G>C | 3_prime_UTR_variant | 3/3 | ENST00000357360.5 | NP_006005.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LAGE3 | ENST00000357360.5 | c.*19G>C | 3_prime_UTR_variant | 3/3 | 1 | NM_006014.5 | ENSP00000349923.4 |
Frequencies
GnomAD3 genomes AF: 0.205 AC: 23011AN: 112171Hom.: 2497 Cov.: 24 AF XY: 0.200 AC XY: 6882AN XY: 34365
GnomAD3 genomes
AF:
AC:
23011
AN:
112171
Hom.:
Cov.:
24
AF XY:
AC XY:
6882
AN XY:
34365
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.163 AC: 29335AN: 180373Hom.: 2213 AF XY: 0.177 AC XY: 11537AN XY: 65307
GnomAD3 exomes
AF:
AC:
29335
AN:
180373
Hom.:
AF XY:
AC XY:
11537
AN XY:
65307
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.130 AC: 139892AN: 1072709Hom.: 8166 Cov.: 26 AF XY: 0.146 AC XY: 49771AN XY: 341287
GnomAD4 exome
AF:
AC:
139892
AN:
1072709
Hom.:
Cov.:
26
AF XY:
AC XY:
49771
AN XY:
341287
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.205 AC: 23018AN: 112224Hom.: 2495 Cov.: 24 AF XY: 0.200 AC XY: 6896AN XY: 34428
GnomAD4 genome
AF:
AC:
23018
AN:
112224
Hom.:
Cov.:
24
AF XY:
AC XY:
6896
AN XY:
34428
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 12, 2021 | - - |
Galloway-Mowat syndrome 2, X-linked Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 19, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at